BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3734848)

  • 1. Prognosis of clinical stage I melanoma patients with positive elective regional node dissection.
    Koh HK; Sober AJ; Day CL; Lew RA; Kopf AW; Lamar W; Ben Cosimi A; Wood WC; Mihm MC; Malt RA
    J Clin Oncol; 1986 Aug; 4(8):1238-44. PubMed ID: 3734848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
    Bachaud JM; Shubinski R; Boussin G; Chevreau C; David JM; Viraben R; Bonafé JL; Daly NJ
    Eur J Surg Oncol; 1992 Oct; 18(5):442-8. PubMed ID: 1426294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.
    Veronesi U; Adamus J; Bandiera DC; Brennhovd IO; Caceres E; Cascinelli N; Claudio F; Ikonopisov RL; Javorskj VV; Kirov S; Kulakowski A; Lacoub J; Lejeune F; Mechl Z; Morabito A; Rodé I; Sergeev S; van Slooten E; Szcygiel K; Trapeznikov NN
    N Engl J Med; 1977 Sep; 297(12):627-30. PubMed ID: 895764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of elective lymph node dissection in malignant melanoma of the extremities and trunk. An analysis in view of the sentinel lymph node biopsy].
    Zimmermann T; Andresen S; Schmitt H; Padberg W
    Zentralbl Chir; 2001 Apr; 126(4):279-82. PubMed ID: 11370389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma.
    van Egmond DB; Welvaart K; Hermans J; Ruiter DJ
    Neth J Surg; 1990 Apr; 42(2):43-6. PubMed ID: 2348926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concept of lymph node dissections in patients with malignant melanoma.
    Stankard C; Cruse CW; Cox C; Wells KE; King J; Reintgen DS
    Ann Plast Surg; 1992 Jan; 28(1):33-8. PubMed ID: 1642404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of elective lymph node excision in melanoma of the trunk].
    Zimmermann T; Buhr J; Kelm C; Padberg W
    Zentralbl Chir; 1996; 121(6):478-82. PubMed ID: 8767335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of lymphatic outflow directed continuity dissection in melanoma surgery].
    Winter H; Aurisch R; Küchler I
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():115-7. PubMed ID: 9101803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.
    Reintgen DS; Cox EB; McCarty KS; Vollmer RT; Seigler HF
    Ann Surg; 1983 Sep; 198(3):379-85. PubMed ID: 6615058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
    Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
    Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous malignant melanoma of the head and neck.
    Fisher SR
    Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
    Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
    Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
    Binder J; Henneking K
    Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of elective lymph node dissection in stage I malignant melanoma: evaluation by matched pair analysis.
    Rompel R; Garbe C; Büttner P; Teichelmann K; Petres J
    Recent Results Cancer Res; 1995; 139():323-36. PubMed ID: 7597301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional lymph node dissection for malignant melanoma of the extremities.
    Roses DF; Harris MN; Gumport SL; Michelassi F; Coffey JA; Dubin N
    Surgery; 1981 Jun; 89(6):654-9. PubMed ID: 7245026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for lymph node metastasis in malignant melanoma].
    Mussack T; Waldner H; Kharraz-Tavakol A
    Zentralbl Chir; 1996; 121(6):465-8. PubMed ID: 8767332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of cervical lymph nodes in patients with cutaneous melanoma.
    Martin RC; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Colman MH; Gao K; Thompson JF
    Ann Surg Oncol; 2012 Nov; 19(12):3926-32. PubMed ID: 22669449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.